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Purpose: A genetic and clinical study of three unrelated Chinese pedigrees with a variable phenotype of lattice corneal
dystrophy type I (LCD I).
Methods: The eyes of the patients were examined by slit lamp microscopy, and other clinical records were also collected.
Genomic DNA was extracted from peripheral leukocytes of the affected patients and their family members. Exons of the
transforming growth factor β induced TGFBI gene were amplified by polymerase chain reaction and directly sequenced
to verify the mutation. Fifty healthy volunteers were analyzed as normal controls.
Results: Variable atypical clinical features of LCD I were found by slit lamp microscopy in these three Chinese pedigrees.
A heterozygous single base-pair transition from C to T (C417T), leading to amino acid substitution (R124C) in the encoded
TGFBI protein, was detected in all of the affected patients. No mutation was found in unaffected family members and 50
normal controls.
Conclusions: Clinical features of Chinese patients with the same R124C mutation are quite variable even within the same
family. Molecular genetic analysis of TGFBI can offer a rapid, accurate diagnosis of patients with atypical corneal
dystrophies.
Lattice  corneal  dystrophy  type  I  (LCD  I;  OMIM
122200)  is  an  autosomal  dominantly  inherited  corneal
amyloidosis that is characterized by thin branching refractive
lines in the anterior corneal stroma, leading to progressive
opacification, painful bilateral recurrent corneal erosions, and
severe visual defect. LCD I always manifests itself in the first
few  decades  of  life  especially  within  the  second  decade.
Mutations in the human transforming growth factor β induced
(TGFBI) gene are the main causes of LCD I [1].
TGBFI is located on the long arm of chromosome V
(5q31) and encodes for the adhesion molecule [2], which is
an  extracellular  matrix  adhesion  protein  inducible  by
transforming  growth  factor  β  (TGFBIp).  TGBFI  was  first
isolated by Skonier et al. [3]. It is a prominent protein in the
cornea, skin, and matrix of many connective tissues. Based on
the  molecular  genetic  study  of  5q31-linked  autosomal
dominant  corneal  dystrophy,  the  correspondence  of  the
genotype-phenotype  has  been  recognized  that  specific
mutation causes the defined form of corneal dystrophy CD
[4].  Molecular  genetic  studies  of  5q31-linked  corneal
dystrophies have demonstrated a clear genotype-phenotype
correlation as specific TGFBI gene mutations cause defined
forms of CD. For example, R124C has been identified as the
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most frequent mutation associated to LCD I throughout the
world [5-11].
Here, we report three unrelated Chinese families with the
identical mutation of R124C in TGFBIp. Two families are
Han  Chinese,  another  is  a  descendant  of  Han  and  Inner
Mongolia. Patients in these families show remarkable variable
phenotypes  of  LCD  I.  The  facts  indicate  that,  with  the
exception  of  the  typical  form  of  LCD  I  with  the  R124C
mutation  described  before,  Chinese  LCD  I  patients  with
R124C mutation also have variable atypical clinical features
even within the same family. This is the first report of the
phenotypic variability of the R124C mutation in Chinese LCD
I pedigrees.
METHODS
Informed, written consents were obtained from all participants
according  to  the  Declaration  of  Helsinki.  The  study  was
approved by the internal board of the Shandong Eye Institute
(Qingdao, China).
Three unrelated Chinese pedigrees of LCD were obtained
for  our  study  (Figure  1).  Thirty-six  family  members  (19
patients, 15 unaffected and 2 young asymptomatic relatives)
from these three Chinese families participated in our study.
Fifty age-matched healthy Chinese volunteers participated in
the study as normal controls. Control subjects were recruited
from medical students, hospital staff members, and residents.
All of control subjects had a negative family history for LCD
with negative history for ophthalmic disease and without any
systemic diseases.
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1234Ophthalmologic  examinations:  Complete
ophthalmologic  examinations  were  performed  on  the
probands and other patients of these three Chinese families.
The  patients  underwent  vision  examination,  slit  lamp
biomicroscopy, applanation tonometry, fundus examination,
and anterior segment photography.
Genetic analysis: Genomic DNA was isolated from the
whole blood of participants by the standard phenol chloroform
method.  TGFBI  was  analyzed  by  direct  genomic  DNA
sequencing  of  exons  4,  10,  12,  and  14.  The  forward  and
reverse oligonucleotide primers were described previously
[5]. Polymerase chain reaction (PCR) was performed in a
Figure 1. The family hereditary patterns of three Chinese pedigrees.
The pedigrees show autosomal dominant transmission of the disease.
The arrows indicate the probands, the asterisks indicate subjects who
underwent clinical and molecular analyses, black symbols represent
affected subjects, and gray symbols represent young subjects who
carry the same mutation but still remain asymptomatic.
volume of 50 μl in a DNA Thermal Cycler (Perkin Elmer,
Norwalk, CT). PCR conditions were as follows: 5 min at 94 °C
followed by 30 cycles of 94 °C for 1 min, 60 °C for 1 min,
and 72 °C for 1 min with a final extension step at 72 °C for
10 min.
Each PCR fragment was purified (QIAquick, Qiagen,
Hilden, Germany), and then both strands were subsequently
analyzed by direct sequencing in an ABI 3700 automated
DNA  sequencer  using  the  Big  Dye  Terminator  Cycle
sequencing reaction kit (Perkin-Elmer, Applied Biosystems
Division, Foster City, CA). Sequence results were compared
with the wild type TGFBI sequence (GenBank AY149344).
The other family members and 50 Chinese controls were
screened  for  the  presence  of  R124C  mutation  by  PCR
amplification and then by direct sequencing of PCR products.
RESULTS
Clinical evaluation: The transmission patterns of these three
Chinese pedigrees are consistent with autosomal dominant
inheritance (Figure 1). General clinical data of patients from
the three families were shown in Table 1, Table 2, and Table
3. The average age of onset was 20, 19, and 19.8 years old,
respectively. Some patients such as IV-10, the proband of
family A, showed typical clinical features of LCD I (Figure
2A). He was 20 years old when he had bilateral recurrent
corneal  erosions  and  progressive  visual  defect.  Slit  lamp
Figure 2. Slit lamp photographs of the affected family members with
LCD I due to an R124C mutation in TGFBI. A: The eye of proband
in family A (IV-10) shows the typical lattice lines of LCD I (white
arrow). B and C: III-4 of family A (B) and II-5 of family C (C) show
diffuse  opacity  occupying  the  central  cornea  with  superimposed
amorphous deposits (yellow arrow), which is quite different from
typical LCD I. III-4 from family A also manifested thin branching
refractive lines in the anterior corneal stroma (white arrow). D: The
eye  of  the  proband  of  family  B  (III-3)  shows  a  diffuse  opacity
throughout the cornea, and no lattice lines could be found. There is
also neovascular infiltration from the limbus of the cornea (black
arrows).
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1235examination of both eyes revealed thin branching refractive
lines in the anterior corneal stroma. The small lattice-shaped
opacity is the characteristic feature of LCD I, which can be
observed by direct illumination and retroillumination. Such
typical  clinical  features  of  some  patients  illustrated  the
diagnosis of LCD I in these three families.
However, some patients such as III-4 of family A (Figure
2B) and II-5 of family C (Figure 2C) showed quite atypical
features different with typical LCD I. These patients showed
a diffuse opacity both in the corneal epithelium and stroma,
occupying the central cornea with superimposed amorphous
deposits. The tiny intraepithelial microcysts or vesicles were
similar to Meesmann's corneal dystrophy (Meesmann’s CD),
which affects the corneal epithelium. Both patients had once
been diagnosed with Meesmann’s CD when they went to the
hospital for the first time. Even more interesting is that patients
TABLE 1. CLINICAL DATA FOR THE AFFECTED INDIVIDUALS OF FAMILY A WITH TGFBIP MUTATION R124C.
Patient number/ Sex/Age
(years)
Age of onset
(years)
Time of duration
(years)
Surgical treatment (patient’s
age when performed)
Visual acuity (before surgery) Visual acuity (after
surgery)
III-1/M/72 22 50 OU: ND OU: HM —
III-3/F/69 24 45 OU: PKP (59) OU: FC/30cm 0.1
III-4/M/67 27 40 OD: LKP (57) OD: 0.06 OD: 0.4
OS: PKP (57) OS: 0.1 OS: 0.4
IV-1/F/40 20 20 OU:PKP (37) OD: 0.15 OD: 0.4
OS: 0.3 OS: 0.5
IV-2/F/38 21 17 OU: ND OD: 0.6 —
OS: 0.1 —
IV-4/M/35 19 16 OD: PKP (34) OD: 0.1 OD: 0.5
OS: ND OS: 0.2 —
IV-6/M/41 21 20 OD: PKP (31) OD: 0.05 OD: 0.4
OS: ND OS: 0.4 —
IV-8/F/49 18 31 OU: ND OU: 0.5 —
IV-10/M/41 35 20 OD: PKP (33) OD: 0.04 OD: 0.4
OS: * — —
V-3/F/20 19 1 OU: ND OU: 0.8 —
The Snellen visual acuity scale was used in these studies. The asterisk indicates that the patient’s left eye is an artificial eye
resulting  severe trauma in childhood. HM: hand movement; FC: finger count; LKP: lamellar keratoplasty; PKP: penetrating
keratoplasty; ND: not done keratoplasty.
TABLE 2. CLINICAL DATA FOR THE AFFECTED INDIVIDUALS OF FAMILY B WITH TGFBIP MUTATION R124C.
Patient number/ Sex/Age
(years)
Age of onset (years) Time of
duration
(years)
Surgical treatment (Patient’s
age when performed)
Visual acuity (before
surgery)
Visual acuity (after
surgery)
II-1/F/70 20 50 OU: ND OU: HM —
II-3/F/66 18 48 OU: PKP (44) OU: FC/40cm OU: 0.1
III-2/F/47 22 25 OU: ND OU: 0.4 —
III-3/M/43 13 30 OD:PKP (31) OD: HM OD: 0.4
OS: ND OS: 0.5 —
III-5/M/46 21 25 OD: PKP (34) OD: 0.15 OD: 0.4
OS: ND OS: 0.2 —
III-10/F/43 20 23 OU: ND OD: 0.5 —
OS: 0.1 —
III-11/F/40 20 20 OU: ND OU: 0.3 —
IV-3/F/20 19 1 OU: ND OU: 1.0 —
TABLE 3. CLINICAL DATA FOR THE AFFECTED INDIVIDUALS OF FAMILY C WITH TGFBIP MUTATION R124C.
Patient number/Sex/ Age
(years)
Age of onset
(years)
Time of duration
(years)
Surgical treatment (Patient’s
age when performed)
Visual acuity (before
surgery)
Visual acuity (after
surgery)
II-5/M/67 17 60 OU: PKP (62) OU: HM OU: 0.2
III-10/F/35 19 16 OU: ND OU: 0.5 —
III-11/M/32 22 10 OU: ND OU: 0.6 —
III-13/M/40 25 15 OU: ND OU: 0.7 —
III-14/F/37 12 25 OU: ND OU: 0.4 —
III-15/F/33 24 9 OU: ND OD: 0.6 —
OS: 0.1 —
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1236III-4 from family A also manifested thin branching refractive
lines in the anterior corneal stroma (Figure 2B).
The proband of family B (Figure 2D), a 43-year-old man,
was the most severe patient. He showed a diffuse opacity of
throughout the cornea, however, no lattice lines could be
found. Neovascular infiltration from the limbus of the cornea
could be seen by slit lamp microscopy. He also had painful
bilateral recurrent corneal erosions and visual defects since he
was  13  years  old,  and  such  symptoms  progressively
aggravated. He first presented at our hospital when he was 30
years old with severe symptoms where the visual acuity of his
right eye was hand movement (HM). Slit lamp examination
of the right cornea did not reveal any lattice lines but a diffuse
opacity all over the cornea following the recurrence of corneal
erosions. He had been diagnosed with corneal ulcer and had
received long-term antibiotic therapy elsewhere. However,
his elder sister (III-2) manifested clinical features of typical
LCD I.
DNA  analysis:  Direct  sequencing  of  TGFBI  using  the
automated  DNA  sequencer  revealed  that  19  affected
individuals and two young asymptomatic relatives showed the
same mutant pattern whereas 15 unaffected showed the wild
type pattern. The result was confirmed using both sense (S)
and antisense (A) primers. The repetition of the sequencing
confirmed the mutation. A single base-pair transition in exon
4 of TGFBI, leading to an amino acid substitution (C417T,
CGC→TGC,  Arg124Cys)  was  detected  in  all  19  affected
individuals. Figure 3 showed examples of the heterozygous
LCD I-associated mutation of affected patients, and no genetic
defect was recognized in the unaffected individuals.
KRT3 on chromosome 12q13 and KRT12 on chromosome
17q12 has been found to be the main cause of Meesmann’s
CD [12,13], the fact that all these patients were identified with
a  heterozygous  R124C  mutation  in  TGFBI  corrected  the
former diagnosis of these patients with atypical features.
DISCUSSION
Lattice  corneal  dystrophy  is  generally  divided  into  three
subtypes. The classification has been made mainly by clinical
and  pathological  findings.  LCD  I  is  characterized  by
prominent delicate linear opacities that tend to be mainly in
the superficial corneal stroma accompanied with epithelial
erosions.
During  the  past  decade,  several  autosomal  dominant
hereditary corneal dystrophies had been related to mutations
in TGFBI/BIGH3. Nearly 30 different mutations in TGFBI
have been identified in families with variants of LCD [11,
14-20]. Therefore, due to such genetic heterogeneity, it is
necessary to identify which specific mutations are carried by
the patient to assess a final diagnosis. However, in clinical
practice,  we  may  occasionally  encounter  patients  with
atypical  clinical  features  of  corneal  dystrophy,  which  is
difficult to diagnose by clinical features only.
In this present study, we report three Chinese pedigrees
with variable clinical features where misdiagnosis had been
made in some of the patients. Since phenotypic variations
within these families are apparent, some patients’ clinical
features of lattice corneal dystrophy are quite atypical. For this
reason, classifications of the phenotype for these patients are
very difficult. Genetic analysis of TGFBI showed that all
affected members of the family have a heterozygous mutation
of R124C, which suggests they belong to a classification of
LCD I. They are classified into LCD I by the genetic findings,
as  this  mutation  occurs  independently  in  several  ethnic
groups.
Meesmann’s CD is a rare autosomal dominant corneal
dystrophy that preferentially affects young family members.
Therefore, the penetrance of Meesmann’s CD should also be
nearly  50%.  However,  from  these  Chinese  families,  the
penetrance  of  atypical  LCD  I  patients  resembling
Meesmann’s CD is only 5.6%, which does not support the
diagnosis of Meesmann’s CD. Furthermore, the probability of
Figure 3. Results of direct sequence analysis of exon 4 of TGFBI in
the region encompassing codon 124. The asterisk indicates that the
first base of codon 124 in affected family members showed both red
(T) and violet (C) peaks resulting in a single base-pair transition
leading to an amino acid substitution, Arg124Cys (bottom panel).
No equivalent mutation was detected in the control subjects (top
panel).
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1237two  mutations  occurring  in  both  TGFBI  and  KRT3  (or
KRT12)  in  two  unrelated  Chinese  families  should  be
extremely rare. To our knowledge, there is no such report in
other countries. Although we had not done DNA analysis for
KRT3 and KRT12 in the atypical LCD I patients resembling
Meesmann’s CD, we prefer the diagnosis of atypical LCD I
rather than Meesmann’s CD.
This is the first report of phenotypic variability with the
R124C mutation in Chinese LCD I pedigrees. Other reports
about atypical LCD I with R124C mutation have been found
in  a  Greek  family,  a  Japanese  family,  and  a  Bangladeshi
family, which indicates that atypical clinical features could
also  happen  independently  in  different  ethnic  origins
[21-23]. Therefore, to speak of the clinical features of LCD I,
we should keep in mind that it may include two subtypes,
typical and atypical LCD I, even within the same family. The
mechanism  of  the  phenotypic  variability  with  the  same
mutation  and  even  within  the  same  family  still  remains
unknown and needs further study.
Currently, genetic diagnosis plays an important role in
establishing  the  classification  of  corneal  dystrophy.
Molecular genetic analysis could establish reliable clinical
diagnostic criteria and could improve the accuracy of clinical
diagnosis. The technique of DNA diagnosis could also make
prenatal and postnatal DNA diagnosis possible in our clinical
practice.  Once  the  Arg124Cys  mutation  is  detected  in  an
individual from these families at birth, it can be expected that
he or she will develop corneal lattice dystrophy, which may
require keratoplasty in the future.
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